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ABSTRACT 
Heparan sulfate (HS), due to its presence on the cell surface and in the extracellular 
milieu and its ability to modulate cell signaling, has a fundamental role in both 
physiological and pathological conditions. Since decades we have demonstrated the 
occurrence of interactions between glycosaminoglycans and elastic fibers. In 
particular, we have recently shown that HS is present inside elastic fibers and plays a 
role in the assembly and stability of elastin coacervates. Since elastin represents, 
within the extracellular matrix, the component most severely affected during ageing, 
and changes in the synthesis and post-translational modifications of HS have been 
described, possibly influencing cellular behavior and protein interactions, the present 
study has investigated, in two different in vitro experimental models, the role of HS on 
elastin deposition and assembly. Results demonstrate that:1) biological effects of HS 
are partly dependent on the physico-chemical characteristics of the GAGs; 2) HS 
does not affect attachment, viability and growth of human dermal fibroblasts; 3) HS 
does not modify elastin gene expression nor elastin synthesis, but favors alpha-
elastin aggregation and, independently from the age of donors, elastin assembly; 4) 
HS significantly increases the expression of fibulin 5 and these effects are especially 
evident in fibroblasts isolated from ageing donors. These data provide a better 
understanding of the biological role of HS and put forward new perspectives on the 
possibility to restore and/or preserve the elastic component with ageing.  
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INTRODUCTION 
Heparan sulfate (HS) is a glycosaminoglycan (GAG) composed of alternating units of 
hexuronic acid and glucosamine, which is variously sulfate-substituted at different 
positions. Proteoglycans carrying HS chains are ubiquitously expressed at the cell 
surface and in the extracellular matrix and, due to their highly negative charges, 
interact with numerous proteins, including growth factors and extracellular-matrix 
proteins 1. The pleiotropic role of HS sustains the increased interest in this GAG and 
the hope to generate HS-based glycotherapeutics 2. HS has been shown to be 
involved in a variety of patho-physiological processes, including angiogenesis, 
ageing, inflammation and cancer, by regulating cell survival, division, adhesion, 
migration and differentiation 3 and by interacting with various protein domains as in 
the case of amyloid deposition 4 and tropelastin assembly 5-7. We have previously 
demonstrated that isolated HS chains interact with recombinant tropoelastin and with 
peptides encoded by specific exons (EDPs) of the human tropoelastin gene, lowering 
the coacervation temperature and favoring the formation of ordered structures of 
tropoelastin or of EDPs 5. Moreover, it has been demonstrated that HS controls 
fibrillin-1 interactions, possibly modulating tropoelastin binding on the cell surface 8.  
Consistently, we have demonstrated that, within connective tissues as in the human 
dermis, HS containing proteoglycans are associated with the amorphous component 
of elastic fibers 5, supporting the concept that HS–elastin interactions may play a role 
in elastin fibrogenesis and/or in elastin stability. 
Loss of elasticity is a well known paradigm of ageing connective tissue 9, therefore 
maintenance of the morpho-functional properties of the extracellular matrix, and of 
elastic fibers in particular, would represent the gold standard of any approach aiming 
to preserve the elastic compliance of organs and tissues.  
Page 3 of 33
Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801
Rejuvenation Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
4
Aim of the present investigation was to focus on the role of HS on elastin deposition 
and assembly. For this purpose, a natural HS (n-HS) and a semi-synthetic HS (ss-
HS) of different molecular weight were used in two different in vitro models (i.e. 
isolated molecules and cultured fibroblasts). In addition, results have been compared 
with those obtained using a very-low-molecular-mass heparin (VLMM-H), since all 
these molecules belong to the same family of GAGs, although their structural 
diversity, molecular mass and sulfation degree may differently affect GAG-protein 
interactions and cell behavior 2,10.
EXPERIMENTAL  PROCEDURES 
Chemicals  
All reagents were of analytical grade and suitable for ultrastructural analysis, 
molecular biology and cell culture.  
Alpha elastin (EPC, USA) was obtained by fractionation from soluble elastin and the 
molecular weight ranges between 10 and 60 kDa.
GAGs were prepared for research use by Opocrin (Modena-Italy) and consisted in a 
natural HS (n-HS), a semi-synthetic HS (ss-HS) and a Very-Low-Molecular-Mass 
heparin (VLMM-H) (Table 1). For a detailed characterization of GAGs, molecular 
weight was assessed by HPLC SEC methods according to E.P.7 (Heparin Low 
Molecular Mass) for VLMW-H, or to OPOCRIN internal method for n-HS and ss-HS 
(see Table 1); SO3-/COO- ratio was measured on the basis of potentiometric 
evaluations 11, whereas Activated Partial Thromboplastin Time (APTT) was calculated 
using the method described by Basu and coworkers 12.
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Cell cultures  
Human skin fibroblasts from 6 adult (36 ± 7 years) and 3 aged (83 ± 2 years) healthy 
donors, undergoing surgical procedures for traumatic events, were used between the 
3rd and 8th passage in vitro. Cells were obtained after informed consent, according to 
the procedures approved by the Ethical Committee of the Medical Faculty of the 
University of Modena and Reggio Emilia.  
Fibroblasts were grown in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 10% Fetal Bovine Serum (Australian FBS, Gibco, Invitrogen Corporation, NY, 
USA), as already described 13. Cells from each donor were kept separate during all 
experimental procedures. 
Cells were treated with the three different GAGs provided by Opocrin (Modena-Italy), 
as mentioned in the previous paragraph. In a series of preliminary experiments, GAGs 
were added to cell cultures at the final concentration of 10, 50 and 100 µM  in order to 
find the concentration that was low but, at same time, sufficient to be present in 
excess in the extracellular milieu, independently from the amounts of GAGs 
synthesized by cells. 
Cell growth and viability  
Cells were plated in duplicate into 35 mm culture dishes at a density of 1.5 x 105
cells/dish. Every day, cells were observed at the inverted microscope (Leica DM-IL), 
counted with a Neubauer chamber and, in the remaining dishes, the medium, with 
and without GAGs, was replaced. 
Page 5 of 33
Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801
Rejuvenation Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
6
RNA preparation and quantitative Real-Time PCR (qRT-PCR) 
Total RNA was isolated from fibroblasts using the RNeasy Protect cells Mini kit 
(Qiagen, Valencia, CA). Quality and quantity of RNA were checked by 
spectrophotometry and by agarose gel electrophoresis. Total RNA (3 µg) was 
reverse transcribed using Superscript III (Invitrogen) and Oligo dT18 primers 
(Invitrogen) according to the manufacturer’s instructions; conversion was confirmed 
by PCR with CLK2 primers. A negative control was carried out to ensure no DNA 
contamination.  Ten fold diluted cDNA samples were further amplified on an iCycler 
(BioRad) using SYBR® GreenERTMqPCR SuperMix (Invitrogen), according to the 
manufacturer’s instructions. For real-time qRT-PCR the following primer sets were 
used: for elastin (ELN) sense 5’-CAGCTAAATACGGTGCTGCTG-3’, antisense 5’-
AATCCGAAGCCAGGTCTTG-3’ with  an efficiency of 98.6%; for fibulin 5 (FBLN5) 
sense 5’-CGGCACATACTTCTGCTCCTG-3’, antisense 5’-
GCTCACATTCGTTGATGTCTTGG-3’ with an efficiency of 105%; for CDC-like 
kinase 2 (CLK2) sense 5’-ACCTACAACCTAGAGAAGAAGC-3’, antisense 5’-
GGCGAGTGGAGACAATGG-3’  with an efficiency of 105% (Table 1 Supp). Thermal 
cycling parameters were set to 50°C for 2 min, 95°C for 3 min, 45 cycles at 95°C for 
30 sec, an annealing temperature of 59°C for 30 sec and 72°C for 30 sec, followed 
by melting curve analysis with a temperature ranging from 95 to 55°C. 
In each sample, gene expression was normalized to the housekeeping gene CLK2
and compared with control samples, using the Pfaffl method 14. Analyses were 
performed in triplicate, keeping cell dishes separate. 
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Western blot 
Confluent fibroblasts were cultured for 48 h in DMEM + 10% FBS in the presence or 
absence of 10 µΜ  n-HS, ss-HS and VLMM-H.  
For Western blots, cells were mechanically detached from plastic dishes. Total cell 
lysates were analyzed for protein concentration using the Bradford technique 15. 
Equal amounts of proteins were then resolved by 10% polyacrylamide gel under 
reducing conditions. Elastin (ELN) and fibulin 5 (FBLN5) were detected by Western 
blot using anti-ELN rabbit polyclonal antibody (Abcam, Cambridge, UK) (1/200) and 
anti-FBLN5 goat polyclonal antibody (Santa Cruz Biotechnology, USA) (1/1000) in 
blocking buffer (2.5% non-fat milk in TBST). After three washes with TBST, 
membranes were incubated with suitable secondary antibodies HRP-conjugated 
(Abcam, Cambridge, UK). Subsequently, Western blots were visualized using the 
SuperSignal West Pico Chemiluminescent Substrate (Pierce) according to 
manufacturer’s protocols. Densitometric analysis of protein bands was performed 
using the ImageQuant TL v2005 software (GE Healthcare). 
Immunofluorescence 
Human dermal fibroblasts, cultured on glass coverslips (Falcon, Becton Dickson, NJ) 
for 7 days, were fixed in ice cold methanol for 30 min at -20°C. After blocking with 1% 
bovine serum albumin (BSA) in PBS, cells were incubated for 2 h at room 
temperature with the following antibodies diluted 1:100 in PBS: rabbit polyclonal anti-
elastin (Abcam, Cambridge, UK), goat polyclonal anti-fibulin-5 (Santa Cruz 
Biotechnology, USA); mouse monoclonal anti-HS (Seikagaku Corp, Japan), rat 
monoclonal anti-heparan sulfate proteoglycan (Chemicon, USA). After washes with 
PBS, fibroblasts were incubated with secondary antibodies conjugated with either 
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goat anti-rabbit IgG-TRITC (Sigma) diluted 1:200, rabbit anti-goat IgG-FITC (Sigma) 
diluted 1:100, goat anti-mouse IgG-FITC (Sigma) diluted 1:100, rabbit anti-rat IgG-
TRITC (Sigma) diluted 1:100 for 40 min at room temperature. After a final wash, cells 
were visualized with a Leica TCS SP2 confocal microscope.
Negative staining 
Human alpha elastin  with a molecular weight range between 10-60 kDa (EPC, USA) 
was used at a final concentration of 1mg/ml in Tyrode’s physiological solution and 
was examined after incubation at  37°C in the presence or not of n-HS, ss-HS and 
VLMM-H (Opocrin) added in a GAGs:elastin ratio 1:10. This concentration and the 
ratio between elastin and GAGs were selected on the basis of previously reported 
data in order to maximize the effects of glycosaminoglycans on elastin aggregation 5. 
However, in a set of experiments, we have tested also at higher and lower HS 
concentrations (i.e. 1 mg/ml or 50 and 10 µg/ml). Incubations in sterile conditions 
were performed for 24h up to 7 days at 37°C. At different time points, samples were 
mounted on copper grids covered with formvar and carbon. Grids were observed by 
transmission electron microscopy (Jeol JEM 1200EX) after staining with 1% uranyl 
acetate in water. 
Turbidimetry measurements 
Coacervation experiments were performed on a Cary UV50 spectrometer equipped 
with a Peltier temperature controller. In order to use concentrations comparable to 
those of negative staining experiments, α-elastin was dissolved in 50 mM Tris, 150 
mM NaCl, 1 mM CaCl2, pH 7.5 to a final concentration of 1 mg/ml. Temperature was 
increased from 10 °C, at a rate of 1 °C/min, up to 90 °C and absorbance was 
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monitored at 440 nm. The coacervation temperature (Tc) was determined as the 
temperature at 50% maximal absorbance. The effect of HS on coacervation was 
assessed upon the addition of 10, 50 and 100 µg/ml of n-HS, ss-HS or VLMM-H.
RESULTS 
Molecular in vitro model: HS and alpha-elastin coacervation and aggregation 
In order to preliminary evaluate the direct effect of HS on elastin assembly, 
experiments were performed by simply adding HSs to a solution of alpha-elastin 
followed  by incubation for few hours up to several days. 
As expected, alpha-elastin in physiological solution at 37°C formed structures that, 
when examined by negative staining electron microscopy, consisted of 4-5 nm thick 
filaments with tendency to form aggregates as well as bundles (figure 1 A1-3). In the 
presence of n-HS, alpha-elastin always formed huge and rather compact bundles of 
filaments mainly organized in a parallel order (figure 1 B1-3). Bundles were also 
visible after addition of ss-HS, although their shape appeared less linear with an 
irregular and twisted behavior (figure 1 C1-3), suggesting that single filaments could 
be not so tightly packed. Addition of VLMM-H gave ris  to loose waving fibrils as well 
as to irregular aggregates (figure 1 D1-3). Once formed, these structures appeared 
quite stable in solution. The efficiency of HS supplementation on alpha-elastin 
coacervation was quantitatively evaluated by  turbidimetry assay. In these 
experimental conditions, the coacervation temperature of α-elastin, at the 
concentration of 1 mg/ml (i.e. comparable to that used in the negative staining 
experiments), is around 80°C and decreases to approximately 70°C in the presence 
of 10, 50 and 100µg/ml n-HS (Figure 1 E-G), without marked variations depending on 
the dose of this GAG (Figure 1E). By contrast, ss-HS lowered the coacervation 
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temperature of α-elastin to 79°C, 75°C and 70°C after addition of 10, 50 and 
100µg/ml of HS, respectively (Figure 1 F). To be noted that, there were no changes 
in the coacervation temperature after addition of VLMM-H, at all doses used (Figure 
1G). 
Since ss-HS had a dose-dependent effect on the coacervation temperature of α-
elastin, we investigated by negative staining the morphology of elastin aggregates in 
the presence of different concentrations of the GAG (Figure 1 H - K).  Although, no 
significant differences were observed depending on the experimental conditions, at 
higher HS concentrations, bundles appeared slightly more densely packed. As a 
whole, data suggest that different amounts of ss-HS may influence the coacervation 
temperature, i.e. the efficiency of the reaction, with minimal consequences on the 
sovramolecular organization of the aggregates. 
In vitro cell culture model:  fibroblast’s response to HS treatment 
Cell growth and cell viability 
Since elastin deposition depends on cell density as well as on the presence of matrix 
molecules in the extracellular milieu 16, the possible influence of HS on cell adhesion 
was tested by adding n-HS, ss-HS as well as VLMM-H at different concentrations 
(i.e. 10, 50 and 100 µM) to the culture medium at the time of fibroblast plating and 
cell number was evaluated after 24 hours. No significant differences were observed 
in comparison with cells plated in the absence of GAGs, between treatments, or 
depending on donor’s age  (data not shown).  
In a separate set of experiments, the effects of HS on cell proliferation have been 
assessed upon supplementation of GAGs (at the same concentrations as in the 
previous experiment) to the culture medium, after 24 hours from plating. Cells were 
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counted every day until confluence. At passages used in these experiments, all 
fibroblast strains, independently from donor’s age, exhibited good growth capabilities 
and no significant changes were observed upon addition of GAGs nor between 
different treatments (data not shown).  
Furthermore, in order to verify if prolonged HS supplementation was associated to 
cytotoxic effects, GAGs were added to confluent fibroblasts and cell number 
evaluated during the next 10 days. Significant differences in the number of cells or in 
their morphology were never observed (data not shown). 
HS  immunostaining in fibroblasts from adult donors
To confirm that HS supplementation, even at the lower concentration of 10 µM, lead 
to higher amounts of this GAG on the cellular monolayer, we have immunodetected 
HS positive epitopes comparing fibroblasts grown in the presence and in the absence 
of added GAGs. By confocal microscopy, anti-HS antibodies revealed an increased 
labeling in cell cultures supplemented with 10 µM n-HS (figure 2B), compared to 
control fibroblasts (figure 2A). Similar results were obtained upon addition of ss-HS 
(data not shown), suggesting that, even at this very low concentration, HS is 
abundantly present in the medium and may interact with cells  at their surfaces. 
Moreover, since all cells have been carefully washed before fixation, the more 
intense fluorescence observed upon HS supplementation indicate that either added 
and newly synthesized HS-containing GAGs are tightly associated to cells and to the 
extracellular matrix formed in vitro by fibroblasts.  
Effect of HS on elastin and fibulin 5 expression in fibroblasts from adult donors 
In cell cultures, deposition of morphologically recognizable elastic aggregates can be 
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observed after confluence as a network of interwoven filaments deposited on and 
among cells (figure 3C). The organization of these aggregates was affected by the 
type of GAG added to the culture medium (figure 3D-F). In particular, both n-HS 
(figure 3D) and ss-HS (figure 3E) appeared to favor the formation of the elastin 
network with thicker and more densely packed filaments. By contrast, VLMM-H 
induced the formation of more globular structures and a less organized meshwork 
(figure 3F).  
Therefore, similarly to previously described observations (figure 1), HS appear to 
favor the coalescence of tropoelastin molecules into interwoven strands. In particular, 
supplementation of n-HS and ss-HS gave rise to similar results, whereas addition of 
VLMM-H exerted little effects.  
In order to discriminate if the elastin network deposited upon addition of n-HS and ss-
HS is due for instance to an effect on elastin assembly or on elastin synthesis, 
Western blot and RT-PCR analyses have been performed on fibroblast cell cultures 
from adult donors (figure 3A-B).  
The addition of n-HS, ss-HS and VLMM-H did not exert any significant change in 
elastin mRNA expression in comparison to untreated cells (Figure 3A). These results 
were in agreement with those at protein level, the elastin present in the cellular 
monolayer being quantified by Western blot  (figure 3B).  
Data indicate that HSs have negligible effects on both elastin mRNA and protein 
levels. Therefore, from these in vitro experiments, it can be suggested that HSs do 
not influence tropoelastin synthesis, rather they would seem to favor tropoelastin 
assembly.  
Since fibulin 5 is an important matrix molecule functioning as a scaffold for elastic 
fibers 17,18 the effect of HS on this protein has been investigated. At mRNA level, a 
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significant increase of fibulin 5 gene expression was always evident after treatment 
with n-HS, whereas ss-HS and VLMM-H  only moderately affected the different cell 
strains (figure 4A). At protein level, either by Western blot (figure 4B) and by 
immunofluorescence (figure 4C-F) a significant increase of fibulin 5 accumulation 
was measured after addition of n-HS and ss-HS as well as of VLMM-H, suggesting 
that accumulation of this protein could be the result of increased mRNA expression 
and of  molecular interactions. 
Effect of HS on elastin and fibulin 5 expression in fibroblasts from aged donors 
Since elastin and fibulin 5 are known to be negatively affected by ageing, the 
biological  role of  HS was investigated also in fibroblasts from donors more than 80 
years old. First of all we have investigated if the expression of HS is modified, 
depending on the age of donors, Figure 5 shows by immunostaining the  
accumulation of HS in  fibroblasts from adult (figure 5A) and old donors (figure 5B). 
Cultures from aged subjects exhibited a reduced number of positive epitopes 
scattered on the cell surface. Consistently, also the expression of HS-containing 
proteoglycans, as perlecan, (figure 5C-D) was significantly reduced in cells from 
aged donors.  
On these premises we have investigated the effects of HS supplementation on the 
expression of elastin and fibulin 5. As shown in figure 6, fibulin 5 expression at 
mRNA (figure 6A) and protein (figure 6B) levels were significantly down-regulated in 
fibroblasts from aged compared to those from adult donors. This trend was 
completely reversed upon addition of ss-HS and the effects appeared well evident at 
mRNA and protein levels (figure 6B). Moreover, elastic fiber deposition, as observed 
by confocal microscopy (figure 6 panels E and F), appeared increased in cell cultures 
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treated with ss-HS (figure 6F), in the absence of any significant change in elastin 
mRNA (figure 6C) and protein (figure 6D) expression, indicating that indirect 
mechanisms could be responsible for elastin accumulation. 
CONCLUSIONS 
Since decades it has been demonstrated that glycosaminoglycans (GAGs) are 
normal constituents of elastic fibers 19, suggesting that they may contribute to deliver 
tropoelastin molecules from cells to growing elastic fibers 20 modulating the stability 
of these polymers 21. In ageing and in pathologic conditions, GAGs and GAGs-
containing proteoglycans, similarly to other matrix constituents, go through changes 
in their expression and post-translational modifications 22,23. Moreover, they suffer 
from unbalanced degradative processes, being responsible for altered interactions 
between matrix proteins and between cells and matrix 24,25, thus contributing  to 
morpho-functional alterations of connective tissues, as observed for instance in 
photoageing 26 and in aged blood vessels 27. 
Due to their negligible turnover, and the consequent susceptibility to endogenous and 
exogenous noxae, elastic fibers represent, within connective tissues, the component 
most severely affected by ageing 9,28.   
Although heparan sulfates (HS) has been shown to interact with a number of 
proteins, changing their structural conformation and causing their aggregation, as 
recently demonstrated in the process of amyloidogenesis 4, we have recently 
demonstrated that this GAG is able to promote the coacervation of tropoelastin 
molecules and of specific tropoelastin peptides 5. However, it has to be elucidated if 
HS effects on elastin assembly are due only to direct interactions of the GAG with 
specific elastin domains and/or if they may also elicit  changes in cellular behavior. 
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Therefore, in the present study, the role of HS on tropoelastin deposition and 
assembly has been investigated on different in vitro experimental models. Moreover, 
since HS-containing proteoglycans can be degraded in vivo to products of various 
size with distinct physical-chemical and biological properties on cells and on matrix 
components 1-3, HS of different size and sulfation ratio were assessed.
Results from the molecular in vitro model indicate that the coacervation temperature 
of alpha-elastin is modified by the presence of both n-HS and ss-HS, although n-HS, 
even at the lowest concentration, was already very efficient, whereas ss-HS lowered 
the coacervation temperature in a dose-dependent way, suggesting that structural 
HS characteristics may have a specific impact on macromolecule interactions. 
Moreover, morphologic evaluation of elastin aggregates, after incubation at 37°C of 
the same amount of alpha-elastin as in the coacervation experiments, showed that 
the presence of HS favored the formation of filamentous  structures that appeared 
more elongated and densely organized after n-HS supplementation. By contrast, the 
effect of VLMM-H was more heterogeneous in terms of structural organization of 
elastin aggregates, as it was negligible also in terms of coacervation process 
activation. These data are in agreement with the hypothesis that: i) HS  specifically 
interacts with tropoelastin 5-7, ii) interactions may occur also in the absence of living 
cells 29; iii) interactions seem to depend, at least in part, on the structural 
characteristics of the HS chain.  
Therefore, HSs with longer chains and/or lower sulfation rate seem to be very 
efficient in favoring tropoelastin assembly. Interestingly, it has been demonstrated 
that sulfation of HS increases with age 21, suggesting that this modification might 
have detrimental consequences on connective tissues 27. Although, further 
investigations are required in order to discriminate on the precise contribution of 
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molecular weight and sulfation characteristics on the rheological properties 
sustaining HS-elastin interactions, present data highlight the specificity of these 
interactions, depending not only on tropoelastin sequences, as previously 
demonstrated 5, but also on HS characteristics. 
However, the role of HS on elastin fibrillogenesis may also represent the result of 
changes in cell behavior and in the cellular response to exogenously added HS. 
To test this hypothesis, we have set up a series of experiments using human dermal 
fibroblasts cultured in the presence of the same GAGs used in the molecular in vitro 
model.  
First of all, results demonstrate that HS supplementation, differently to what has been 
described for smooth muscle cells 30, does not appear to interfere with cell adhesion, 
nor with cell proliferation or cell viability of dermal fibroblasts and therefore it can be 
excluded that effects on matrix molecules could be the consequence of changes in 
cell density or cell number. Moreover, data indicate that cells (i.e. smooth muscle 
cells and fibroblasts) may behave differently, depending on the environment or on 
their “functional imprinting”.  
Morphological evaluations of the elastic meshwork formed in vitro by dermal 
fibroblasts, support the positive effects of HS on elastin assembly. Surprisingly, 
elastin synthesis and expression were not modified by any HS added to the system, 
suggesting that HSs act in the extracellular compartment favoring elastin 
accumulation and assembly, without up-regulating mRNA nor protein expression, 
consistently with data from molecular in vitro data. However, in a cell culture system, 
other matrix molecules, beside elastin and HS, may influence the 
formation/organization of the elastin network.      
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As recently demonstrated for fibrillin-1 8, GAG supplementation may influence 
synthesis and interactions of various molecules within elastic fibers. One possible 
candidate could be fibulin 5, a protein known to bind to tropoelastin promoting its 
coacervation 31 and inducing elastic fiber assembly 17,18. We have recently provided 
in vitro evidence that elastin secretion/deposition in the extracellular space 
undergoes an age-dependent decline irrespective of the level of mRNA expression or 
of the amount of protein detectable by Western blot in the cellular monolayer 32 and 
that reduced FBLN5 expression may be responsible for the low deposition of elastin 
aggregates in cultures of in vitro aged fibroblasts, as well as in fibroblasts isolated 
from old donors 32.  Moreover, in the present study we have provided evidence that in 
fibroblasts cultured from ageing donors there is a marked reduction of HS as well as 
of HS containing proteoglycans, consistently with the modified properties of the aged 
cellular and extracellular environment 23-24.  
The stimulatory effects of HS supplementation on fibulin 5 expression, clearly evident 
also in fibroblasts isolated from ageing donors, may contribute to the increased 
elastin staining observed on the cell surface upon HS treatment, even in the absence 
of changes in elastin mRNA and protein expression in the cellular monolayer. 
To be noted that although n-HS was the most effective at mRNA levels, also ss-HS 
and VLMW-H induced fibulin 5 protein accumulation at similar values. These data 
indicate that, at least in part, HS-mediated effects could be due to interactions with 
“heparin-binding domains”, and that HS glycosaminoglycans might exert similar 
modulatory properties on fibulin 5 expression and accumulation 10.  
Since fibulin 5 is a well known ageing marker 32,33, being significantly down-regulated 
with ageing, it is of great interest the possibility that HS is capable to reinduce the 
synthesis of this protein, thus contributing to the elastin accumulation we have 
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observed in the extracellular matrix of  fibroblasts from ageing donors.  Although in 
vivo experiments are necessary to fully evaluate the potential role of HS as a 
rejuvenation compound by investigating the effects of the GAG on the formation and 
functional properties of mature crosslinked elastic fibers, never the less, present data 
highlight the pleiotropic role of HS, also in the ageing context. 
Moreover, in accordance with previous data 32,34, in order to have a structurally 
organized elastic component, it is necessary the coordinated expression, deposition 
and assembly of elastin as well as of other molecules as fibulin 5 and GAGs with 
appropriate size and physical-chemical characteristics. This concept is of paramount 
importance in vivo, where changes in the characteristics of matrix components, 
occurring for instance with age, have profound consequences on functional 
parameters related to stiffness, tissue elasticity and compliance.  
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Table 1: Glycosaminoglycans’ characteristics 
        
 n-HS ss-HS VLMW-H 
  
      
Preparation 
  
  
  
  
  
  
Natural heparan sulphate 
extracted from horse 
spleen according to 
OPOCRIN patent 
WO8904328  
Semi-synthetic heparan 
sulphate obtained from 
heparin, by N-
desulfatation followed by 
N-acetylation according 
to OPOCRIN patent EP 
0557887 B1, examples 
1-2 
Very Low Molecular 
Mass Heparin obtained 
by peroxyradicalic 
depolymerization of 
heparin according to 
OPOCRIN patent 
US4,933,326
Mw (kD) 29,5 10,3 3,1 
      
SO3- / COO- 0,8 1,4 2,3 
      
Spec. rotation [a20D] + 74° + 44° + 43° 
      
Anticoagulant activity 
U/mg < 1 5 6 
(APTT test)     
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LEGEND TO FIGURES 
Figure 1. Transmission electron microscopy of negatively stained alfa-elastin 
aggregates after 24h incubation at 37°C in the absence of glycosaminoglycans (A1-3) 
and in the presence of n-HS (B1-3), ss-HS (C1-3) and VLMM-H (D1-3) at  a GAG:elastin 
ratio of  1:10.  Since  GAGs-elastin interactions may lead to different types of 
aggregates, three representative images are provided for each experimental 
condition. Panels E-G reported coacervation experiments using alpha elastin (αE) at 
the concentration of 1mg/ml and n-HS, ss-HS and VLMM-H at 10, 50 100 µg/ml. Only 
n-HS and ss-HS appeared to reduce the coacervation temperature. Panels H-K 
illustrate the aggregates formed upon addition of 10 (H), 50 (I), 100 (J) and 1000 (K) 
µg/m of ss-HS to alpha-elastin. Bar 1µm 
Figure 2. Confocal microscopy showing the immunostaining for heparan sulfate in  
human dermal fibroblasts grown in the absence (A) or in the presence of  10 µM n-
HS (B). Bar: 10 µm 
Figure 3. Elastin expression in fibroblasts cultured for 7 days in presence or in 
absence of 10µM n-HS, ss-HS and VLMM-H. Elastin mRNA (A) and protein (B) 
expression have been evaluated by RT-PCR and Western blot, respectively. Data 
are expressed as mean values of two experiments performed in triplicate with all 
different fibroblasts cell lines and indicate the fold increase of treated compared to 
control cells set at one. In panel B, a representative Western blot is also shown.  
Confocal microscopy (C-F) showing the immunostaining for elastin in untreated 
fibroblast cell culture (C) and upon addition of n-HS (D), ss-HS (E) and VLMM-H (F). 
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In the presence of n-HS (D) and ss-HS (E) a meshwork made of thick and densely 
packed aggregates can be observed, while addition of VLMM-H (F) causes elastin 
deposition in thinner and sometimes globular aggregates. Bar: 10 µm 
Figure 4. Fibulin 5 expression in fibroblasts cultured for 7 days in presence or in 
absence of 10µM n-HS, ss-HS and VLMM-H. Fibulin 5 mRNA (A) and protein (B) 
expression have been evaluated by RT-PCR and Western blot, respectively. Data 
are expressed as mean values of two experiments performed in triplicate with all 
different fibroblasts cell lines and indicate the fold increase of treated compared to 
control cells set at one. In panel B, a representative Western blot is also shown.  
*p<0.05 vs control. Confocal microscopy (C-F) showing the accumulation of fibulin-5 
in untreated fibroblast cell culture (C) and upon addition of n-HS (D), ss-HS (E) and 
VLMM-H (F).  The positive effect of HS supplementation is clearly visible. Bar: 10 µm
Figure 5. Confocal microscopy showing the immunostaining for heparan sulfate (A-
B) and for HS containing proteoglycans (C-D) in human dermal fibroblasts grown 
from adult (A,C) and old (B,D) donors.  Bar: 10 µm 
Figure 6. Fibulin 5 (A-B) and elastin (C-D) expression in fibroblasts from adult (Cadl) 
and old (Cold-ss-HS) donors. ss-HS supplementation on fibroblasts from aging donors 
(Cold +ss-HS) is ineffective on elastin expression, but significantly increases fibulin 5 
expression at protein (B) and mRNA (A) levels.  Data are expressed as mean values 
of two experiments performed with all different fibroblast strains and indicate the fold 
increase of treated and untreated Cold cells compared to fibroblasts from adult donors 
(Cadl). Confocal microscopy (E-F) showing the elastin network on cells from old 
Page 26 of 33
Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801
Rejuvenation Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
3
donors untreated (E) and treated with ss-HS (F). *p<0.05 Cold vs Cadl; # p<0.05 Cold-
ss-HS vs Cold+ss-HS. Bar: 10 µm. 
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